A critical advance in cancer study is arising with the use of nanobodies to reactivate damaged p53. This crucial malignant suppressor protein is frequently lost in various forms of malignancies, causing uncontrolled https://worldsocialindex.com/story7057070/mini-antibodies-reactivate-tumor-suppressor-p53-the-new-pathway-for-malignant-therapy